Drug-Induced Alopecia
January 2015
Research cited in this study
32 / 32 results
research Anidulafungin-Induced Alopecia: A Case Report
This case report suggests that anidulafungin may be associated with hair loss, highlighting the need for physicians to monitor this potential adverse effect.
research Hepatitis C Treatment and Alopecia Totalis
This case report detailed alopecia universalis developing shortly after hepatitis C treatment with peg-interferon, ribavirin, and telaprevir, suggesting potential immune-related links between interferon treatment and alopecia areata.
research Retinoids Putting the 'A' in Alopecia
This study suggests that dietary vitamin A may influence alopecia development and progression, but the mechanisms remain unclear, highlighting the interplay between genetics and nutrition in these hair loss conditions.
research Irreversible Alopecia Universalis During Treatment With Pegylated Interferon-Ribavirin for Chronic Hepatitis C Virus Infection: Case Report and Literature Review
This case study reports the first instance of irreversible alopecia universalis occurring during pegylated interferon-ribavirin therapy in a man with hepatitis C infection, without evidence of immunological or thyroid disorders.
research Drugs and Hair Loss: Mechanisms and Clinical Implications
This review discusses possible medication-induced hair loss and the need to exclude other confounding factors like stress and illness; it reports no new clinical findings and emphasizes careful assessment before attributing hair loss to medications.
research Chemotherapy-Induced Alopecia
This review discusses current knowledge and management strategies for chemotherapy-induced alopecia, highlighting the need for better research prioritization and providing patient support materials, but reports no new clinical results.
research Three Cases of Alopecia Following Clinical Islet Transplantation
This study describes three female islet transplant recipients who unexpectedly developed alopecia areata about 7 years post-transplant, with a possible link to immunosuppressive treatment regimens.
research Tufted Hair Folliculitis in a Woman Treated with Trastuzumab
This case report presents an instance of tufted hair folliculitis in a woman treated with trastuzumab, highlighting a previously unreported skin side effect of this selective HER2 inhibitor.
research Telogen Effluvium Due to Recombinant Interferon Alpha-2b
This study observed that long-term recombinant interferon alpha-2b therapy was associated with considerable hair loss in some patients, indicated by a telogen effluvium pattern on trichograms.
research Alopecia Associated with Gabapentin in the Treatment of Neuropathic Pain
In this case study, researchers observed that gabapentin may cause alopecia, as a patient developed significant hair loss shortly after starting the medication for neuropathic pain, which reversed upon discontinuation.
research Onset of Lichen Planopilaris During Treatment with Etanercept
This study documented the onset of lichen planopilaris during treatment with etanercept.
research Reversible Alopecia Universalis Secondary to PEG-Interferon Alpha-2b and Ribavirin Combination Therapy in a Patient with Chronic Hepatitis C Virus Infection
This case report documents a reversible instance of complete body hair loss (alopecia universalis) in a patient undergoing chronic hepatitis C treatment with pegylated interferon alpha-2b and ribavirin, with hair regrowth observed within three months after therapy completion.
research Drug Reactions Affecting Hair: Diagnosis
This article reviews drug-induced hair changes, highlighting that while many drugs are occasionally linked to hair loss, this connection has been conclusively established for only a few, and such hair loss is typically reversible.
research Hair Loss Pattern Due to Chemotherapy-Induced Anagen Effluvium: A Cross-Sectional Observation
This study suggests that chemotherapy-induced anagen effluvium represents patterned hair loss, with most patients retaining hairlines, but patterns do not vary significantly by age, symptoms, or chemotherapy type.
research Enoxaparin-Induced Alopecia in Patients with Cerebral Venous Thrombosis
This study reported that enoxaparin may cause alopecia in patients treated for cerebral venous thrombosis, with hair growth resuming naturally after the treatment ended.
research Drug-Induced Hair Disorders
This article reviews how various drugs may cause hair loss, stimulate growth, or alter hair characteristics, but reports no new clinical results; drug-induced hair loss is typically reversible.
research Alopecia Associated With Treatment With Selective Serotonin Reuptake Inhibitors (SSRIs)
This study concluded that alopecia is a rare side effect of SSRIs, with sertraline showing a higher association compared to citalopram, particularly among women.
research Hair Loss After Extracorporeal Membrane Oxygenation
This study observed that hair loss, which resolved on its own within six months, was reported by some patients after extracorporeal membrane oxygenation, suggesting it as a potential side effect.
research Diffuse Alopecia in a Hemodialysis Patient Caused by a Low-Molecular-Weight Heparin, Tinzaparin
This case report describes a hemodialysis patient whose hair loss reversed after switching from tinzaparin to enoxaparin, suggesting tinzaparin-induced alopecia.
research Telogen Effluvium: Causes, Diagnosis, and Treatment
This article reviews the concept of telogen effluvium and emphasizes the importance of identifying triggers and using diagnostic investigations to determine the cause of hair loss, without reporting new results.
research Practical Management of Hair Loss
This article describes an organized diagnostic approach for identifying nonscarring and scarring alopecias to aid family physicians in making accurate in-office diagnoses, but it reports no new clinical findings.
research Hair Loss in Psychopharmacology
This article reviews the association between psychopharmaceuticals and medication-induced alopecia, noting that hair regrowth typically occurs after discontinuing or reducing the medication, while mineral supplements' effectiveness remains unclear.
research Hair Loss in Psychopharmacology
This review discusses the potential for mood stabilizers, antidepressants, and some antipsychotic and antianxiety drugs to induce alopecia and reports no clinical results.
research Retinoids And Hair Growth
This review explores the psychological and medical implications of hair loss, suggesting it may indicate a serious systemic disorder, but it does not present new research findings.
research Alopecia and Mood Stabilizer Therapy
This review discusses the association between mood stabilizers and alopecia, providing diagnosis insights and management options, but reports no new clinical results.
research A Randomized Trial of Minoxidil in Chemotherapy-Induced Alopecia
This study found that in women undergoing chemotherapy after breast surgery, topical minoxidil significantly shortened the duration of hair loss compared to a placebo without significant side effects.
research Captopril and Alopecia: A Case Report and Review of Known Cutaneous Reactions in Captopril Use
Captopril may cause hair loss, as shown by a woman's hair regrowing after stopping the medication.
research Alopecia and Drug Eruption of the Scalp Associated with a New Beta-Blocker, Nadolol
This report describes a case in which the use of the beta-blocker nadolol was associated with infiltrative dermatitis and significant alopecia, which resolved and resulted in total hair regrowth after discontinuation of the drug.
research Hair Loss and Lithium
This article reviews the relationship between hair loss and lithium but does not provide any new clinical findings.
research Metoprolol and Alopecia
This study describes a case where metoprolol was associated with reversible telogen effluvium, suggesting a similar mechanism of alopecia as seen with other beta-adrenoceptor antagonists.
research Propranolol-Induced Alopecia
Propranolol can cause reversible hair loss.
research Inhibition of Keratinizing Structures by Systemic Drugs
This article reviews how various chemical agents affect human hair and skin, suggesting the need for more research on their pharmacologic and dermatologic effects; it does not report new experimental results.
Related Research
8 / 8 results
research A Review of Hair Anatomy and Animal Models for Alopecia
This review examines the anatomy and physiology of hair, focusing on the hair growth cycle and various types of alopecia, using animal models such as mice and rats to study the condition's pathophysiology and aid in developing new treatments.
research What Can Complex Dietary Supplements Do for Hair Loss and How Can It Be Validly Measured: A Review
This review discusses the strengths and weaknesses of existing studies on complex dietary supplements for hair loss, emphasizing the need for valid measurement methods like TrichoScale® to quantify effectiveness; it reports no new results.
research Hair Loss (Alopecia or Baldness)
This article reviews various aspects of hair and hair loss but does not report new research findings.
research A Bald Statement: Current Approaches to Manipulate Miniaturization Focus Only on Promoting Hair Growth
This article reviews the cellular dynamics affecting dermal papilla size in androgenetic alopecia and suggests targeting DP size could improve therapies, but it presents no new clinical data.
research Treatments of Hereditary Hair Loss (Alopecia)
This article discusses the nature and causes of hair loss, including hereditary factors, but reports no new clinical findings.
research Stress Related Hair Disorders
research Alopecia
This review discusses the biology of hair growth, diagnostic methods of hair loss, and treatments for alopecia areata and androgenetic alopecia, without reporting new clinical results.
research Treatment of Hair Loss
This article discusses the treatment of androgenetic alopecia and alopecia areata with finasteride and minoxidil but reports no new clinical results.